Changes in HbA1c Between 2011 and 2017 in Germany/Austria, Sweden, and the United States: A Lifespan Perspective,Diabetes Technology & Therapeutics

当前位置： X-MOL 学术 › Diabetes Technol. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Changes in HbA1c Between 2011 and 2017 in Germany/Austria, Sweden, and the United States: A Lifespan Perspective
Diabetes Technology & Therapeutics ( IF 5.7 ) Pub Date : 2022-01-05 , DOI: 10.1089/dia.2021.0225
Anastasia Albanese-O'Neill ₁ , Julia M Grimsmann _{2,

3} , Ann-Marie Svensson _{4,

5} , Kellee M Miller ₆ , Klemens Raile ₇ , Karin Akesson _{8,

9} , Peter Calhoun ₆ , Beate Biesenbach ₁₀ , Katarina Eeg-Olofsson ₅ , Reinhard W Holl _{2,

3} , David M Maahs _{11,

12} , Ragnar Hanas _{13,

14}

Affiliation

Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL, USA.
Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany.
German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany.
Centre of Registers in Region Västra Götaland, Gothenburg, Sweden.
Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
Jaeb Center for Health Research, Tampa, Florida, USA.
Department of Pediatric Endocrinology and Diabetes, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Department of Paediatrics, County Hospital Ryhov, Jönköping, Sweden.
Department of Pediatrics, University Hospital Linz, Kepler University, Linz, Austria.
Division of Pediatric Endocrinology, Stanford Diabetes Research Center, Stanford, California, USA.
Department of Health Research and Policy (Epidemiology), Stanford University School of Medicine, Stanford, California, USA.
Department of Pediatrics, NU Hospital Group, Uddevalla, Sweden.
Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

Aims: This study assessed hemoglobin A1c (HbA1c) across the lifespan in people with type 1 diabetes (T1D) in Germany/Austria, Sweden, and the United States between 2011 and 2017 to ascertain temporal and age-related trends.

中文翻译：

2011 年至 2017 年间德国/奥地利、瑞典和美国 HbA1c 的变化：从生命周期的角度来看

目的：本研究评估了 2011 年至 2017 年间德国/奥地利、瑞典和美国 1 型糖尿病 (T1D) 患者整个生命周期的血红蛋白 A1c (HbA1c)，以确定时间和年龄相关趋势。

更新日期：2022-01-06

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11